Overall, in addition to acting as a conventional chemotherapeutic drug, DTX can upregulate the expression of PD-L1 in tumor cells, providing a more effective target for ICB therapy, and promote the uptake of αPD-L1. The gene discussed is CD274; the disease is neoplasm.